Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Maternal and Pediatric Nutrition Highlights Original Article

Observations of body mass index in Duchenne muscular dystrophy: a longitudinal study

Subjects

Abstract

Background/Objectives:

Nutritional issues that are associated with Duchenne muscular dystrophy (DMD) remain poorly understood. The aim of this analysis was to describe and explore longitudinal observations of body mass index (BMI) in a cohort of children with DMD.

Subjects/Methods:

Anthropometric and clinical characteristics were collected retrospectively and longitudinally for boys with DMD seen in two large neuromuscular clinics. BMI Z-scores were determined using the Centers for Disease Control and Prevention reference values for children (2000).

Results:

Medical records (n=193) were examined from which 75% were included for analysis. The mean age of the cohort at the time of data collection was 11.9 years, with 72% of patients currently or previously using steroids. The highest prevalence of obesity based on the BMI Z-score was 50% at the age of 10 years. Longitudinally, BMI Z-scores from the age of 2 to 12 years plot approximately one s.d. above the mean, after which there is a marked and progressive decline. BMI gainers were identified for whom BMI Z-score increased by 1.65 units compared with the 0.09 units in non-gainers. BMI gainers were younger when they had their first BMI measurement (5.9 vs 7.2 years), and this measure was significantly lower compared with the non-gainers (BMI Z-score: 0.04 vs 1.17). In this cohort, BMI was associated with age, ambulatory status and lung function.

Conclusions:

This study demonstrates that boys with DMD using steroid therapy experience shifts in BMI. A declining BMI appears to be associated with increasing age. Interpretation of growth patterns is limited here by a lack of normative growth references in DMD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010; 9: 77–93.

    Article  Google Scholar 

  2. Davidson ZE, Truby H . A review of nutrition in Duchenne muscular dystrophy. J Hum Nutr Diet 2009; 22: 383–393.

    Article  CAS  Google Scholar 

  3. Willig TN, Carlier L, Legrand M, Riviere H, Navarro J . Nutritional assessment in Duchenne muscular dystrophy. Dev Med Child Neurol 1993; 35: 1074–1082.

    Article  CAS  Google Scholar 

  4. McDonald CM, Abresch RT, Carter GT, Fowler WM Jr, Johnson ER, Kilmer DD et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil 1995; 74: S70–S92.

    Article  CAS  Google Scholar 

  5. Martigne L, Salleron J, Mayer M, Cuisset J-M, Carpentier A, Neve V et al. Natural evolution of weight status in Duchenne muscular dystrophy: a retrospective audit. Br J Nutr 2011; 105: 1486–1491.

    Article  CAS  Google Scholar 

  6. Biggar WD, Harris VA, Eliasoph L, Alman B . Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 2006; 16: 249–255.

    Article  CAS  Google Scholar 

  7. Strober JB . Therapeutics in Duchenne muscular dystrophy. NeuroRx 2006; 3: 225–234.

    Article  CAS  Google Scholar 

  8. Balaban B, Matthews DJ, Clayton GH, Carry T . Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. Am J Phys Med Rehabil 2005; 84: 843–850.

    Article  Google Scholar 

  9. Bianchi ML, Biggar D, Bushby K, Rogol AD, Rutter MM, Tseng B . Endocrine aspects of Duchenne muscular dystrophy. Neuromuscul Disord 2011; 21: 298–303.

    Article  Google Scholar 

  10. Sorva RA, Turpeinen MT . Asthma, glucocorticoids and growth. Ann Med 1994; 26: 309–314.

    Article  CAS  Google Scholar 

  11. Kuczmarski R, Odgen C, Grummer-Strawn L, Flegal K, Guo S, Wei R et al. CDC Growth Charts: United States. Advance Data from Vital and Health Statistics; No 314. National Center for Health Statistics: Hyattsville, Maryland, USA, 2000.

    Google Scholar 

  12. National Health and Medical Research Council. Clinical Practice Guidelines for the Management of Overweight and Obesity in Children and Adolescents. Commonwealth of Australia: Canberra, Australia, 2003.

  13. Pallant J SPSS Survival Manual, 4th edn. Allen & Unwin: Crows Nest, NSW, Australia, 2011.

    Google Scholar 

  14. Nagel BHP, Mortier W, Elmlinger M, Wollmann HA, Schmitt K, Ranke MB . Short stature in Duchenne muscular dystrophy: a study of 34 patients. Acta Paediatr 1999; 88: 62–65.

    Article  CAS  Google Scholar 

  15. Andrada LE, De Vito EL . Clinical and spirometric alterations in patients with Duchenne muscular dystrophy. Medicina 1996; 56: 463–471.

    CAS  PubMed  Google Scholar 

  16. Biggar WD, Gingras M, Fehlings DL, Harris VA, Steele CA . Deflazacort treatment of Duchenne muscular dystrophy. J Pediatr 2001; 138: 45–50.

    Article  CAS  Google Scholar 

  17. Department of Health and Aging. 2007 Australian National Children’s Nutrition and Physical Activity Survey—Main Findings. Commonwealth of Australia: Barton ACT, Australia, 2008.

  18. Pessolano FA, Suarez AA, Monteiro SG, Mesa L, Dubrovsky A, Roncoroni AJ et al. Nutritional assessment of patients with neuromuscular diseases. Am J Phys Med Rehabil 2003; 82: 182–185.

    PubMed  Google Scholar 

  19. Bushby K, Bourke J, Bullock R, Eagle M, Gibson M, Quinby J . The multidisciplinary management of Duchenne muscular dystrophy. Curr Paediatr 2005; 15: 292–300.

    Article  Google Scholar 

  20. Leung DG, Germain-Lee EL, Denger BE, Wagner KR . Report on the Second Endocrine Aspects of Duchenne Muscular Dystrophy Conference December 1–2, 2010, Baltimore, Maryland, USA. Neuromuscul Disord 2011; 21: 594–601.

    Article  CAS  Google Scholar 

  21. Gauld LM, Kappers J, Carlin JB, Robertson CF . Height prediction from ulna length. Dev Med Child Neurol 2004; 46: 475–480.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Z E Davidson.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Davidson, Z., Ryan, M., Kornberg, A. et al. Observations of body mass index in Duchenne muscular dystrophy: a longitudinal study. Eur J Clin Nutr 68, 892–897 (2014). https://doi.org/10.1038/ejcn.2014.93

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2014.93

This article is cited by

Search

Quick links